What is spondylodiscitis and how is it diagnosed and treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Spondylodiscitis: Definition, Diagnosis, and Treatment

Spondylodiscitis is a serious infection involving the vertebral body (spondylitis) and intervertebral disc (discitis) that requires urgent MRI imaging for diagnosis, tissue biopsy before antibiotics when feasible, and 6-12 weeks of antimicrobial therapy, with surgery reserved for neurological deficits, spinal instability, or treatment failure. 1

What is Spondylodiscitis?

Spondylodiscitis represents an infection of the vertebral endplate and adjacent disc space that typically occurs via hematogenous spread. 2 In adults, the disc is avascular and becomes infected following an initial septic embolus to the highly vascularized vertebral endplate, with subsequent spread across the disc to the opposing vertebral body. 2, 3

Key anatomical patterns:

  • Single-level involvement occurs in 65% of patients 2, 4
  • Contiguous multilevel infection occurs in approximately 20% of cases 2, 4, 3
  • Non-contiguous multilevel disease occurs in about 10% of patients 2, 4, 3

Clinical presentation typically includes:

  • Back pain (present in 85.3% of patients) combined with fever 1, 5
  • Elevated inflammatory markers (ESR and CRP) 1
  • Neurological deficits occur in up to 50% of patients when epidural extension or paravertebral abscesses compress nerve roots 3, 6

Most common causative organisms:

  • Staphylococcus aureus accounts for up to 80% of pyogenic cases 5, 6
  • Tuberculosis, brucellosis, and fungal pathogens are important non-pyogenic causes 1, 5

Diagnostic Approach

Initial Clinical Suspicion

Suspect spondylodiscitis in any adult presenting with new or worsening back/neck pain PLUS fever OR elevated ESR/CRP. 1 Do not rely on plain radiographs, as they lack sensitivity for early disease and changes may take months to appear. 1, 7

Imaging Strategy

MRI with contrast is the diagnostic modality of choice, demonstrating 96% sensitivity and 94% specificity. 1, 4 Obtain sagittal views of the entire spine to identify the full extent of involvement, epidural abscess formation, and paravertebral soft tissue extension. 1, 3

Classic MRI findings include:

  • Focal or linear increased signal in adjacent vertebral endplates 2
  • Involvement of the intervening disc space 1
  • Endplate irregularities, erosions, or destruction on correlative CT 2
  • Extension to epidural space or paravertebral soft tissues 2, 3

[18F]FDG PET/CT should be considered when:

  • Symptoms are within 14 days of onset (before MRI changes develop) 1, 4
  • MRI findings are inconclusive despite elevated inflammatory markers 1
  • Evaluating for multilevel disease, given that 30% of cases involve multiple levels 1, 3

Microbiological Diagnosis

Obtain tissue diagnosis via image-guided or surgical biopsy BEFORE initiating antibiotics whenever possible, as biopsy has higher diagnostic yield than blood cultures. 1, 4 Blood culture positivity is only 53-54% in pyogenic and brucellar cases. 5 Tissue sampling with 16S rRNA PCR is superior to standard microbiological examination. 6

Exception to pre-treatment biopsy: If a patient had documented S. aureus bacteremia within the prior three months and MRI shows compatible spinal changes, treatment can be started directly without biopsy. 1

If the first biopsy is non-diagnostic, repeat sampling and specifically test for tuberculosis, brucellosis, and fungal pathogens. 1

Laboratory Evaluation

Measure ESR and CRP at baseline for monitoring treatment response. 1, 4 Pyogenic spondylodiscitis typically shows higher inflammatory markers compared to tuberculous or brucellar disease. 5

Treatment Algorithm

Antibiotic Therapy

Initiate empirical antibiotic therapy immediately after obtaining cultures (or immediately in septic/neurologically compromised patients), using vancomycin (15-20 mg/kg IV every 12 hours) combined with EITHER:

  • Cefepime (2 g IV every 8-12 hours), OR 1, 4
  • A carbapenem: meropenem (1 g IV every 8 hours), imipenem-cilastatin (500 mg IV every 6 hours), or ertapenem (1 g IV every 24 hours), OR 1, 4
  • Ceftriaxone (2 g IV every 24 hours) plus metronidazole (500 mg IV every 8 hours) 1, 4

This regimen covers MRSA and gram-negative organisms. 1

Adjust antibiotics based on culture results and sensitivities once available. 1, 4

Duration and Route

Administer IV antibiotics for 2-4 weeks, then transition to oral antibiotics with excellent bioavailability. 1, 4, 6 Do NOT use oral β-lactams due to inadequate bioavailability. 1

Total treatment duration is 6-12 weeks. 1, 4 A randomized trial demonstrated that 6 weeks is non-inferior to 12 weeks, with clinical cure rates of 90.9% in both groups. 4

Switch to oral therapy when:

  • CRP decreases 1
  • Any significant epidural or paravertebral abscesses have been drained 1

Surgical Indications

Surgery is indicated for:

  • Neurological deficits with spinal cord compression 1, 4, 6
  • Progressive neurological deterioration 1
  • Spinal instability or severe deformity 4, 6, 7
  • Failure of conservative therapy with insufficient pain relief 4, 6, 7
  • Need for tissue diagnosis when biopsy is non-diagnostic 4, 6, 7

Epidural abscess causing nerve root compression at multiple levels requires urgent surgical decompression. 1, 3 Paravertebral abscesses compressing exiting nerve roots in neural foramina necessitate drainage. 1, 3

Surgical approach options:

  • Anterior approach allows for disc and bone debridement 7
  • Posterior approach is indicated when posterior elements are involved or epidural abscess is present 7
  • Instrumentation use in the presence of infection remains controversial 7

Monitoring Treatment Response

Monitor ESR and CRP as primary means to evaluate treatment response. 4, 6 A clear reduction in CRP and ESR in the first few weeks indicates good prognosis. 6 The treatment endpoint is normalization of inflammatory markers and osseous fusion of the mobile segment. 8

Critical Pitfalls to Avoid

Do not miss multilevel disease: Assess the entire spine with sagittal imaging, as 30% of cases involve multiple levels (20% contiguous, 10% non-contiguous). 1, 3 The valveless Batson plexus allows bidirectional blood flow, enabling bacterial seeding at multiple non-contiguous levels. 3

Do not delay imaging: Plain radiographs are inadequate for early diagnosis—proceed directly to MRI when clinical suspicion is high. 1, 7

Do not start antibiotics before obtaining tissue diagnosis unless the patient is septic, neurologically compromised, or has documented recent S. aureus bacteremia. 1 Premature antibiotics reduce diagnostic yield.

Do not use oral β-lactams for initial or early oral therapy due to inadequate bioavailability. 1

Monitor for treatment failure risk factors: Multidisc disease, concomitant epidural abscess, S. aureus infection, advanced age, diabetes, and significant comorbidities increase failure rates to 10-30%. 1, 5 Mortality is approximately 2-15% depending on severity. 6, 8

Watch for complications: Prolonged antibiotic treatment increases risk of drug intolerance and Clostridium difficile colitis. 1 Chronic back pain may persist even after successful infection clearance. 9

References

Guideline

Spondylodiscitis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Spondylodiscitis and Multilevel Radiculopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Spondylodiscitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Spondylitis - Spondylodiscitis - an Update.

Zeitschrift fur Orthopadie und Unfallchirurgie, 2019

Research

Surgical treatment of spondylodiscitis. An update.

International orthopaedics, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.